Concepts (47)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lymphoma, Large B-Cell, Diffuse | 2 | 2022 | 139 | 0.860 |
Why?
|
| Chlorambucil | 1 | 2023 | 5 | 0.860 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2023 | 183 | 0.750 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2024 | 225 | 0.730 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 4 | 2024 | 1239 | 0.420 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 1889 | 0.330 |
Why?
|
| Burkitt Lymphoma | 1 | 2024 | 146 | 0.200 |
Why?
|
| MAP Kinase Signaling System | 1 | 2024 | 316 | 0.200 |
Why?
|
| Rituximab | 1 | 2023 | 156 | 0.200 |
Why?
|
| Anthracyclines | 1 | 2022 | 36 | 0.200 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2024 | 332 | 0.190 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2022 | 127 | 0.190 |
Why?
|
| Disease-Free Survival | 1 | 2023 | 860 | 0.180 |
Why?
|
| Disease Management | 1 | 2024 | 519 | 0.170 |
Why?
|
| Thrombophilia | 1 | 2020 | 43 | 0.170 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2024 | 530 | 0.170 |
Why?
|
| Medicare | 1 | 2023 | 422 | 0.170 |
Why?
|
| Blood Coagulation | 1 | 2020 | 120 | 0.160 |
Why?
|
| Venous Thromboembolism | 1 | 2020 | 161 | 0.140 |
Why?
|
| Lung Neoplasms | 2 | 2024 | 1598 | 0.130 |
Why?
|
| Thrombosis | 1 | 2020 | 519 | 0.120 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 1126 | 0.120 |
Why?
|
| Inflammation | 1 | 2020 | 1414 | 0.100 |
Why?
|
| Prognosis | 1 | 2022 | 4553 | 0.100 |
Why?
|
| Retrospective Studies | 4 | 2024 | 16231 | 0.100 |
Why?
|
| Humans | 8 | 2024 | 124401 | 0.100 |
Why?
|
| Aged | 3 | 2024 | 19478 | 0.090 |
Why?
|
| Mutation | 1 | 2024 | 5805 | 0.090 |
Why?
|
| Risk Factors | 1 | 2022 | 10149 | 0.070 |
Why?
|
| United States | 1 | 2023 | 10773 | 0.070 |
Why?
|
| Aged, 80 and over | 3 | 2024 | 6470 | 0.070 |
Why?
|
| Withholding Treatment | 1 | 2024 | 68 | 0.060 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2024 | 120 | 0.050 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2024 | 236 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 281 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2021 | 1482 | 0.040 |
Why?
|
| Melanoma | 1 | 2024 | 832 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2020 | 586 | 0.030 |
Why?
|
| Age Factors | 1 | 2021 | 2805 | 0.030 |
Why?
|
| Time Factors | 1 | 2024 | 6273 | 0.030 |
Why?
|
| Incidence | 1 | 2020 | 3086 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2021 | 4733 | 0.020 |
Why?
|
| Neoplasms | 1 | 2024 | 2800 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2024 | 12286 | 0.020 |
Why?
|
| Male | 2 | 2024 | 61027 | 0.020 |
Why?
|
| Female | 2 | 2024 | 66303 | 0.020 |
Why?
|
| Animals | 1 | 2020 | 34146 | 0.010 |
Why?
|